Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
267
datasets available to search
ShareScore release 0.9.0
Dataset results
267 results for “Biliary tract cancer”
The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer
ClinicalTrials.gov study NCT05036486. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT06778031. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT06230471. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
ClinicalTrials.gov study NCT00142480. IPD Sharing: Not stated. Countries: 1. Publications: 0.
New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
ClinicalTrials.gov study NCT04896931. IPD Sharing: NO. Countries: 1. Publications: 0.
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT07025174. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Durvalumab Combined With Surufatinib as Maintenance Therapy in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT06255262. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT02433639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT07392541. IPD Sharing: NO. Countries: 1. Publications: 0.
Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT01234051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer
ClinicalTrials.gov study NCT06178445. IPD Sharing: NO. Countries: 1. Publications: 0.
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary Tract Cancer (ASCEND-BTC)
ClinicalTrials.gov study NCT05667350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT05935579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
XmAb20717 in Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT05297903. IPD Sharing: NO. Countries: 1. Publications: 0.
Trastuzumab in HER2-positive Biliary Tract Cancer
ClinicalTrials.gov study NCT03613168. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive
ClinicalTrials.gov study NCT03110328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment
ClinicalTrials.gov study NCT05170438. IPD Sharing: NO. Countries: 1. Publications: 0.
Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT05820906. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer
ClinicalTrials.gov study NCT05056116. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer
ClinicalTrials.gov study NCT02558959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.